The 2026 NCCN updates represent a convergence of biological precision and patient-driven lifestyle changes. By integrating ...
New urinary biomarkers show promise for bladder cancer detection and recurrence prediction. Learn more about this non-invasive diagnostic approach.
New research identifies distinct urinary metabolites linked to bladder cancer and recurrence, raising hope for non-invasive ...
The clinical trial is designed to catch cancer at its earliest molecular signal and intervene before it becomes metastatic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results